GBIM - GlobeImmune, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.01M
Enterprise Value 3-8.28M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.32
Price/Book (mrq)0.19
Enterprise Value/Revenue 3-1.33
Enterprise Value/EBITDA 64.27

Trading Information

Stock Price History

Beta (3Y Monthly) -0.66
52-Week Change 3-77.39%
S&P500 52-Week Change 32.19%
52 Week High 30.4800
52 Week Low 30.0350
50-Day Moving Average 30.0913
200-Day Moving Average 30.1281

Share Statistics

Avg Vol (3 month) 39.48k
Avg Vol (10 day) 37.53k
Shares Outstanding 55.75M
Float 4.37M
% Held by Insiders 10.00%
% Held by Institutions 10.31%
Shares Short (Jul 15, 2016) 4129.39k
Short Ratio (Jul 15, 2016) 40.1
Short % of Float (Jul 15, 2016) 43.49%
Short % of Shares Outstanding (Jul 15, 2016) 42.25%
Shares Short (prior month Jun 15, 2016) 4114.55k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2015
Most Recent Quarter (mrq)Mar 31, 2016

Profitability

Profit Margin -33.30%
Operating Margin (ttm)-33.30%

Management Effectiveness

Return on Assets (ttm)-10.25%
Return on Equity (ttm)-66.24%

Income Statement

Revenue (ttm)6.21M
Revenue Per Share (ttm)1.08
Quarterly Revenue Growth (yoy)-20.60%
Gross Profit (ttm)3.81M
EBITDA -1.94M
Net Income Avi to Common (ttm)-2.07M
Diluted EPS (ttm)-0.3600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.69M
Total Cash Per Share (mrq)1.51
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.28
Book Value Per Share (mrq)0.37

Cash Flow Statement

Operating Cash Flow (ttm)-5.9M
Levered Free Cash Flow (ttm)-1.65M